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Purpose: To develop a model for the identification of early
symptomatic knee osteoarthritis (OA) based on clinical, x-ray
and biomarker variables using MRI as the gold standard in a
population based study.
Methods: Subjects, 40-79 years, with knee pain were assem-
bled, stratified by age decade and gender, in a cross-sectional
population-based study and evaluated clinically, with MRI, x-ray
and biomarkers. MR cartilage (MRC) defects were scored 0-4 on
6 knee joint surfaces with subsequent application of a weighted
MRC (wMRC) score, which reflects the mean depth of a given
cartilage defect (MRC 0 or 1 = wMRC 0, MRC 2 = wMRC 0.25,
MRC 3 = wMRC 0.75, MRC 4 = wMRC 1.0). The sum of all
wMRC scores was used to determine the total knee score. Sub-
jects were classified as No OA (NOA) (total knee score = 0), early
OA (EOA) (total knee score 0.1-1.9) or advanced OA (AOA) (total
knee score ≥ 2). X-rays were read using Kellgren-Lawrence [KL]
0-4 grading. Biomarkers (Bio) were log transformed and included
serum and urine C2C and C1,2C, 846 epitope, CPII, CTX-II,
COMP and hyaluronic acid. Clinical variables assessed in the
models were age, gender, body mass index (BMI), alignment,
gait, quadriceps atrophy, effusion and crepitus. A continuation-
ratio ordinal regression model was used to simultaneously model
2 binary responses (normal versus non-normal; early versus ad-
vanced OA assuming abnormality is present) that represent two
stages of disease progression. Partial proportional odds ratios
were used to allow for different effects of a variable in the 2
stages. A bootstrap-based approach was adapted for variable
selection. Models were evaluated based on prediction accuracy,
Akaike’s Information Criterion (AIC), where a lower value indi-
cates a better model fit, and the C-index, where a 1.0 score
indicates a perfect model fit. All reported results are adjusted for
stratum sampling weights.
Results: Of 255 subjects, 33 (13%) had NOA, 106 (43%) had
EOA, 116 (44%) had AOA. The ability of different models to
identify NOA, EOA and AOA is summarized in Table 1.
The variables that were selected in the Clinical+Xray+Bio model
were age, gender, BMI, effusion, gait, quadriceps atrophy, KL
grade, urine CTX-II, serum CPII/C2C, and urine C2C.
Conclusions: While the addition of x-ray to the clinical model
enhances prediction for early and advanced OA, but not No OA,
the addition of biomarkers improves the prediction of No OA dra-
matically. In this population-based study, we conclude that people
with knee pain can be classified into different subgroups of OA
P224 – Table 1. Identification of OA groups
Model Identification of OA group (%) Overall identification (%) AIC C-Index
NOA (n=33) EOA (n=106) AOA (n=116)
Clinical variables only 12% 71% 72% 64% 415 0.87
X-ray only 0% 83% 73% 68% 367 0.88
Biomarkers only 6% 63% 71% 59% 425 0.85
Clinical + X-ray 15% 78% 83% 72% 350 0.91
Clinical + Bio 49% 71% 80% 72% 364 0.91
Clinical + X-ray + Bio 52% 76% 85% 77% 317 0.94
with reasonable accuracy, particularly for early and advanced
stage of OA. The diagnostic implications of these findings will be
of importance to future investigations of early knee OA.
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Purpose: To examine the relationship between obesity/anthro-
pometric measures and osteoarthritis (OA) at the knee and hip
in a UK case-control cohort - GOAL ("Genetics of Osteoarthritis
and Lifestyle").
Methods: The GOAL cohort is an age and gender matched
group of Caucasians comprised of hip (n=1008) and knee
(n=1042) OA cases, referred to hospital with severe symptomatic
large joint OA for consideration of surgery, and asymptomatic
controls without large joint OA (n=1123) referred to hospital for
intravenous urography. Height, weight, waist and hip circumfer-
ence were measured during clinical assessment and retrospec-
tive estimates of weight from each decade were collected as part
of an interview-based questionnaire on environmental factors.
Odds ratios, crude and adjusted (e.g. age, social class, occu-
pation, physical activity, smoking, oestrogen load (females only),
95% confidence intervals and p-values were calculated using
logistic regression.
Results: BMI was a strong risk factor for knee and hip OA with
obesity (BMI ≥30 kg/m2) showing greater risk than overweight
(BMI ≥25<30 kg/m2). The risk was greater for knee than hip
OA, and greater for women than men at the knee. All trends
were significant at p<0.001 after adjustment for confounders. An
increasing risk (p<0.001) was observed for hip and knee OA
with duration of being overweight (never, current, middle age
onwards, always). This risk was greater for women than men,
e.g. in the always overweight group women (OR=14.2 (8.1-24.9)
versus men (OR=4.1 (2.7-6.3)). There was a risk associated
with increasing waist-hip ratio (WHR) (knees OR=1.7 (1.4-2.1),
hip OR=1.6 (1.3-2.0) both p<0.001), which was lost after ad-
justment for BMI. A similar effect was observed with waist and
hip circumference (WC and HC). However, stratifying the WHR
analysis by BMI identified an increased number of obese fe-
male knee OA cases with a lower WHR, when compared to
obese female controls (57.4%, p=0.022) although both low and
high WHR groups had significant OR for OA when compared to
controls. In women, the cases (n=182) had smaller WC (mean
101.6±1.4) compared to the obese female controls (n=135)
(mean 111.1±1.7) p<0.001 but similar HC (123.0±1.6 versus
120.1±1.6) respectively, p=0.015). The data suggest that having
a greater WC or HC gives an increased risk (OR=1.7, P=0.01
and 1.5, p=0.045 respectively) for knee OA in this obese female
group. Since WC reflects central obesity which is a feature of the
metabolic syndrome we looked for an association with related
co-morbidities: high WHR was associated with diabetes (OR=2.3
(1.1-5.3) p=0.035) and showed a trend towards an association
